Sean M. Jeffery, PharmD, CGP, FASCP
Associate Clinical Professor
University of Connecticut
Clinical Pharmacy Specialist - Geriatrics
VA Connecticut Healthcare System
West Haven, CT
Robert B. Santulli, MD
Associate Professor of Psychiatry
Dartmouth Medical School
Dartmouth-Hitchcock Medical Center
Pharmacists: 1 contact hour (0.1 CEU)
Nurses: 1 contact hour Medium
THIS ACTIVITY WAS ORIGINALLY PRESENTED AS A LIVE AUDIOCONFERENCE SERIES BEGINNING OCTOBER 19, 2009. IF YOU RECEIVED CREDIT FOR PARTICIPATING IN THE AUDIOCONFERENCE, YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ONLINE ACTIVITY.
Depression and anxiety cause significant morbidity and mortality in the United States, and they frequently occur together, causing a greater impact than when either of these illnesses occurs alone. In the elderly, considerable overlap exists between risk profiles for anxiety and depression. As patients age, underdiagnosis and undertreatment for psychiatric disorders, including depression, increases. Depression is often difficult to diagnose in the elderly, and even if adequately diagnosed, elderly patients often do not receive adequate treatment. Furthermore, only 40% of patients respond to the first choice of antidepressant medication. Continuing education will help clinicians recognize and overcome the barriers that hinder the proper diagnosis and management of comorbid depression and anxiety in the elderly, ultimately improving clinical outcomes for these patients. Program Developer/Facilitator
. Target Audience
Pharmacists, VA pharmacists, and geriatric/LTC nurses
Upon completion of this application-based educational activity, the participant should be able to:
Review strategies to improve the recognition, evaluation, and diagnosis of depression and/or anxiety in older adults.
Consider both psychotherapeutic and pharmacologic approaches to improve outcomes in patients with depression and/or anxiety.
Optimize benefits and minimize risks of pharmacologic therapy in older patients with depression and/or anxiety.
Outline methods to effectively monitor symptoms and response to treatment in older patients with depression and/or anxiety.
Identify indicators of treatment failure and appropriate next steps in this population.
In accordance with the standards set forth by the Accreditation Council for Pharmacy Education, it is the policy of the American Society of Consultant Pharmacists to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any relevant financial relationships or other relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation.
The intent of this disclosure is not to prevent a presenter with relevant financial relationships or other relationships from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speakeršs interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Sean M. Jeffery, PharmD, CGP, FASCP, has no relevant financial relationships to disclose.
Robert B. Santulli, MD, discloses that he has served on speakers bureaus for Forest Laboratories, Eli Lilly and Co., and Novartis Pharmaceuticals.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Pharmacy Continuing Education: The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This application-based activity (ACPE # 203- 999-09-070-H01-P) was developed by ASCP and is approved for 1.0 Contact Hour (0.1 CEU).
Nursing Continuing Education: NADONA/LTC is an approved provider of continuing nursing education by Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Centers Commission on Accreditation #1088. This program provides 1 contact hour by NADONA/LTC.
Participants must successfully complete the post-test (70% or higher) and submit an evaluation to receive credit. A statement of credit will be available immediately if the post-test and evaluation are completed online or within 6 weeks if they are sent by mail.
Commercial Support Statements
Supported by an educational grant from Forest Laboratories, Inc.